Cytosolix
Cytosolix is developing novel derivatives of known small molecule oral oncology drugs that selectively target cancer cells via a universal biomarker of solid tumors, acidity, significantly improving efficacy.
Cytosolix is developing novel derivatives of known small molecule oral oncology drugs that selectively target cancer cells via a universal biomarker of solid tumors, acidity, significantly improving efficacy.